# Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients

> **NCT01207206** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Cancer
- Pain
- Tolerance

## Interventions

- **DRUG:** oral ketamine

## Key facts

- **NCT ID:** NCT01207206
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207206, "Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01207206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*